Stock AnalizInspire Medical Systems, Inc. INSP
Medical/Dental Instruments · IPO 2018 · data as of November 13, 2026
Inspire Medical Systems, Inc. (INSP) is a healthcare company listed in the US with a market value of about $1.8B. In the twelve months to September 30, 2026 it had revenue of $881M and net income of $101M, a net margin of 11.4%.
Its overall Stock Analiz score is 3.0 out of 5 (average). The strongest part is future growth (5/5); the weakest is shareholder returns (0/5).
Key numbers: a P/E of 18.2, a price to free cash flow of 18.1, 5-year revenue growth of 51% a year, a 5-year average ROIC of -3%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 76% below the current price.
Score: 3.0 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Checks not passed
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- Pays a dividend
- Share count down over 3 years (buybacks)
- 20% to 100% of free cash flow returned to shareholders
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $881M | $912M | $803M | $625M | $408M | $233M | $115M | $82M | $51M | $29M | $16M |
| Net income | $101M | $145M | $54M | -$21M | -$45M | -$42M | -$57M | -$33M | -$22M | -$18M | -$19M |
| Free cash flow | $98M | $78M | $91M | $1M | $2M | -$25M | -$56M | -$36M | -$19M | -$16M | -$18M |
| EPS (diluted) | $3.36 | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 | $-2.19 | $-1.40 | $-1.50 | $-14.88 | $-16.90 |
| Net margin | 11.4% | 16.0% | 6.7% | -3.4% | -11.0% | -18.0% | -49.6% | -40.5% | -43.1% | -61.3% | -112.8% |
| ROIC | — | 5.0% | 4.6% | -5.3% | -7.4% | -12.0% | -17.1% | -16.7% | -10.7% | -90.0% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 16 analysts is $69.62, 14% above the current price; targets range from $45.00 to $97.00; the consensus rating is “Hold”; expected EPS is $1.30 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Inspire Medical Systems’s P/E ratio?
About 18.2, based on the last twelve months of diluted earnings per share (forward P/E about 34.1).
Is Inspire Medical Systems stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 76% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Inspire Medical Systems pay a dividend?
Not currently.
Is Inspire Medical Systems a good stock to buy?
We do not give buy or sell advice. Inspire Medical Systems scores 3.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.